SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
If someone's always late, is it time blindness, or are they just being rude? - 2Satellite data reveals a huge solar storm in 2024 shrank Earth's protective plasma shield
- 3Easter Island quarry reveals how Polynesians made enigmatic stone statues
- 47 Moves toward a Sound and Dynamic Way of life
- 5What to know about voluntary chocolate recall
- Which European palace do you fantasy about visiting? Vote!
- WHO issues guidance on GLP-1 drugs for obesity
- Reveal Less popular Authentic Realities You Didn't Learn in School
- The Magnificence of Extraordinariness: Presenting Valuable Adornments and Gemstones
- I watched more than 500 new movies this year. These are the 25 best ones.
- Partake in the Outside: Senior-Accommodating Exercises for 2024
- From Fledgling to Master: Self-awareness in a Side interest
- The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites
- Shredded cheese recall: Multiple brands sold at Aldi, Target and Walmart affected over potential metal fragment contamination
